New study aims to predict who will develop multiple myeloma

NCT ID NCT07214324

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 32 times

Summary

This observational study is looking for biological markers that can predict if early blood disorders (MGUS or SMM) will progress to multiple myeloma, a type of blood cancer. Researchers will analyze genetics, immune cells, and mouth bacteria from 60 patients and compare them to healthy volunteers. The goal is to better identify high-risk individuals and guide future prevention strategies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA (MM) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Istituto Ortopedico Rizzoli IRCCS

    ACTIVE_NOT_RECRUITING

    Bologna, Italy

  • S.C Ematologia - Azienda USL IRCCS di Reggio Emilia

    RECRUITING

    Reggio Emilia, Italy

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••

  • UO Ematologia Azienda Ospedaliero-Universitaria "Policlinico Rodolico San Marco"

    ACTIVE_NOT_RECRUITING

    Catania, Italy

  • UOC di Ematologia, Dipartimento di Oncologia, AOU Policlinico "Paolo Giaccone"

    ACTIVE_NOT_RECRUITING

    Palermo, Italy

Conditions

Explore the condition pages connected to this study.